BridgeMD
Compares treatment options for Critical Illness
Official title The Effect of Continuous Versus Intermittent Enteral Nutrition on Metabolic Outcomes in Critically Ill Patients
ClinicalTrials.gov ID: NCT07173504
What this study is testing
- What it's testing
- The goal of this clinical trial is to investigate the effect of continuous versus intermittent enteral nutrition on metabolic outcomes in critically ill adult patients. The aim of this study is to: To assess the effect of a daytime intermittent tube feeding pattern compared to standard continuous tube feeding on glycaemic control, gastrointestinal function, gastrointestinal hormones, markers of sleep quality and circadian rhythm, and lean body mass and body composition.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Age ≥18 years;
- Receiving or eligible to receive exclusively gastric tube feeding;
- Expected ICU stay ≥48 hours;
- Receiving or anticipated to receive invasive mechanical ventilation within 48 hours after ICU admission.
You likely can't join if
- The treating clinician considers participation in the study clinically contraindicated (e.g., change in feeding regimen, no possibility for placement...
- Death is deemed to be imminent or inevitable during admission, and the attending doctor, patient, or substitute decision-maker is not committed to...
- Pregnancy;
- Expected fasting for ≥12 hours during the study period, for example, due to medical procedures;
- Readmission in last 14 days;
- Patients with burn injuries;
See the full eligibility criteria
- Age ≥18 years;
- Receiving or eligible to receive exclusively gastric tube feeding;
- Expected ICU stay ≥48 hours;
- Receiving or anticipated to receive invasive mechanical ventilation within 48 hours after ICU admission.
- The treating clinician considers participation in the study clinically contraindicated (e.g., change in feeding regimen, no possibility for placement of CGM on arms, not able to receive exclusive gastric tube feeding);
- Death is deemed to be imminent or inevitable during admission, and the attending doctor, patient, or substitute decision-maker is not committed to active treatment;
- Pregnancy;
- Expected fasting for ≥12 hours during the study period, for example, due to medical procedures;
- Readmission in last 14 days;
- Patients with burn injuries;
- Participating in another nutritional intervention study.
The study team makes the final eligibility decision.
Where it's taking place
- Ede, Gelderland, Netherlands
- Deventer, Overijssel, Netherlands
- Enschede, Overijssel, Netherlands
- Groningen, Provincie Groningen, Netherlands
- The Hague, South Holland, Netherlands
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Ede, Gelderland, Netherlands; Deventer, Overijssel, Netherlands; Enschede, Overijssel, Netherlands; Groningen, Provincie Groningen, Netherlands; The Hague, South Holland, Netherlands. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.